NeurOp

About:

NeurOp is a research company developing different drug compounds.

Top Investors: ATDC, Georgia Research Alliance

Description:

NeurOp Corporation, a preclinical stage pharmaceutical company, engages in the development of disease activated small molecules for the treatment of central nervous system (CNS) diseases. It offers therapeutics for CNS indications, including ischemia, neuropathic pain, Parkinson's disease, and Alzheimer's disease. The company was incorporated in 2002 and is based in Atlanta, Georgia.

Total Funding Amount:

$580000

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Atlanta, Georgia, United States

Founded Date:

2002-01-01

Founders:

James O. McNamara, Ray Dingledine, Stephen F. Traynelis

Number of Employees:

1-10

Last Funding Date:

2014-02-24

IPO Status:

Private

Industries: